US30303M1027 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 117.929B 37.18% | 116.609B -1.12% | 134.902B 15.69% | 161.407B 19.65% | ||||||||
EBITDA YoY % growth | 54.72B 38.42% | 42.241B -22.81% | 60.184B 42.48% | 93.587B 55.50% | N/A | |||||||
EBIT YoY % growth | 46.753B 43.10% | 33.555B -28.23% | 49.006B 46.05% | 62.977B 28.51% | ||||||||
Operating Margin | 39.65% | 28.78% | 36.33% | 39.02% | ||||||||
EPS YoY % growth | 13.80 40.96% | 8.58 -37.83% | 14.90 73.66% | 20.42 37.06% | N/A | N/A |
All data in USD
Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 4.85 62.66% | ||||||||||
Revenue Q2Q % growth | 39.046B 22.02% | ||||||||||
EBITDA Q2Q % growth | 23.003B | N/A | N/A | N/A | N/A | ||||||
EBIT Q2Q % growth | 15.092B 57.60% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 4.71 114.09% | 4.40 | 0.31 | 6.98% |
Q4 2023 Q2Q % growth | 5.33 202.84% | 5.06 | 0.27 | 5.40% |
Q3 2023 Q2Q % growth | 4.39 167.68% | 3.70 | 0.69 | 18.52% |
Q2 2023 Q2Q % growth | 2.98 21.14% | 2.97 | 0.01 | 0.23% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 36.455B 27.26% | 36.871B | -416M | -1.13% |
Q4 2023 Q2Q % growth | 40.111B 24.70% | 39.961B | 150M | 0.38% |
Q3 2023 Q2Q % growth | 34.146B 23.21% | 34.233B | -87M | -0.25% |
Q2 2023 Q2Q % growth | 31.999B 11.02% | 31.748B | 251M | 0.79% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0.26% | 12.83% | 0.6% | 14.06% |
Revenue | 0.2% | 4.88% | 0% | 4.46% |